SLC5A2 and autosomal dominant cerebellar ataxia: The decline in mortality related to SCA could be due to advances in cardiopulmonary resuscitation and post-resuscitation care (53), and potentially due to novel hypoglycemic agents such as SGLT-2 inhibitors and GLP-1 agonists.